These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23244352)
1. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark. Olsen J; Jørgensen TR; Kofoed K; Larsen HK BMC Public Health; 2012 Dec; 12():1082. PubMed ID: 23244352 [TBL] [Abstract][Full Text] [Related]
2. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea. Choi I; Lee D; Son KB; Bae S BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300 [TBL] [Abstract][Full Text] [Related]
3. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates. Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study. Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257 [TBL] [Abstract][Full Text] [Related]
5. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples. Lindquist S; Frederiksen K; Petersen LK; Kjær SK Int J Cancer; 2024 Jul; 155(1):61-70. PubMed ID: 38418719 [TBL] [Abstract][Full Text] [Related]
6. The economic burden of human papillomavirus-related precancers and cancers in Sweden. Östensson E; Silfverschiöld M; Greiff L; Asciutto C; Wennerberg J; Lydrup ML; Håkansson U; Sparén P; Borgfeldt C PLoS One; 2017; 12(6):e0179520. PubMed ID: 28651012 [TBL] [Abstract][Full Text] [Related]
7. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study. Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status. Mpunga T; Chantal Umulisa M; Tenet V; Rugwizangoga B; Milner DA; Munyanshongore C; Heideman DAM; Bleeker MCG; Tommasino M; Franceschi S; Baussano I; Gheit T; Sayinzoga F; Clifford GM Int J Cancer; 2020 Mar; 146(6):1514-1522. PubMed ID: 31173641 [TBL] [Abstract][Full Text] [Related]
9. The economic burden of noncervical human papillomavirus disease in the United States. Hu D; Goldie S Am J Obstet Gynecol; 2008 May; 198(5):500.e1-7. PubMed ID: 18455524 [TBL] [Abstract][Full Text] [Related]
10. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers. Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625 [TBL] [Abstract][Full Text] [Related]
12. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis. Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus-related anogenital premalignancies and cancer in renal transplant recipients: A Danish nationwide, registry-based cohort study. Reinholdt K; Thomsen LT; Dehlendorff C; Larsen HK; Sørensen SS; Haedersdal M; Kjaer SK Int J Cancer; 2020 May; 146(9):2413-2422. PubMed ID: 31291470 [TBL] [Abstract][Full Text] [Related]
14. Risk of human papillomavirus-associated cancers among persons with AIDS. Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510 [TBL] [Abstract][Full Text] [Related]
15. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review. Préaud E; Largeron N J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814 [TBL] [Abstract][Full Text] [Related]
16. Familial Clustering, Second Primary Cancers and Causes of Death in Penile, Vulvar and Vaginal Cancers. Zhang L; Hemminki O; Chen T; Zheng G; Försti A; Sundquist K; Sundquist J; Hemminki K Sci Rep; 2019 Aug; 9(1):11804. PubMed ID: 31413311 [TBL] [Abstract][Full Text] [Related]
17. Cervical, Vaginal, and Vulvar Cancer Costs Incurred by the Medicaid Program in Publicly Insured Patients in Texas. Fu S; Fokom Domgue J; Chan W; Zhao B; Ramondetta LM; Lairson DR J Low Genit Tract Dis; 2019 Apr; 23(2):102-109. PubMed ID: 30907776 [TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus-Attributable Cancers - United States, 2012-2016. Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140 [TBL] [Abstract][Full Text] [Related]
19. Determination of Oncogenic Human Papillomavirus (HPV) Genotypes in Anogenital Cancers in Myanmar. Mu Mu Shwe ; Hlaing Myat Thu ; Khin Saw Aye ; Aye Aye Myint ; Mya Thida ; Khin Shwe Mar ; Khin Khin Oo ; Khin Sandar Aye ; Okada S; Kyaw Zin Thant Acta Med Okayama; 2016; 70(2):103-10. PubMed ID: 27094835 [TBL] [Abstract][Full Text] [Related]
20. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis. Gilbert DC; Wakeham K; Langley RE; Vale CL Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]